Abstract
Tetrabenazine (TBZ) depletes presynaptic dopamine in the CNS. It has been found to be beneficial in hyperkinetic movement disorders without carrying the extrapyramidal side effects that are characteristic of neuroleptics.
| Original language | English |
|---|---|
| Pages (from-to) | 2883-2896 |
| Number of pages | 14 |
| Journal | Expert Opinion on Pharmacotherapy |
| Volume | 10 |
| Issue number | 17 |
| DOIs | |
| Publication status | Published - 2009 |
Keywords
- Adrenergic Uptake Inhibitors
- Animal
- Animals
- Drug Interactions
- Humans
- Models
- Nervous System Diseases
- Randomized Controlled Trials as Topic
- Tetrabenazine
Fingerprint
Dive into the research topics of 'Tetrabenazine'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver